Underlying mechanisms of nephroprotective effects with SGLT2i in CKD

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
SGLT2 inhibition in CKD: Discussing the key questions and evidence
Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
- Rajiv Agarwal, MD
The clinical landscape of managing patients with CKD: Where are we now and what can we expect?
The clinical landscape of managing patients with CKD: Where are we now and what can we expect?
SGLT2 inhibition in CKD: Discussing the key questions and evidence
The clinical landscape of managing patients with CKD: Where are we now and what can we expect?
- Will Herrington, MD